You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 12, March 22, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Perinatal hepatitis B virus transmission in the United States. Prevention by passive-active immunization

C. E. Stevens, P. T. Toy, M. J. Tong, P. E. Taylor, G. N. Vyas, P. V. Nair, M. Gudavalli and S. Krugman

Among infants born to women in whom sera are positive for both the hepatitis B surface antigen and the e antigen, 85% to 90% are infected with hepatitis B virus and become chronic hepatitis B surface antigen carriers. In a study to assess the effectiveness of passive-active prophylaxis (hepatitis B immune globulin and hepatitis B vaccine) of such infants, we screened 18,842 pregnant Asian-American women: 8.7% were positive for hepatitis B surface antigen and 3.0% were also positive for hepatitis B e antigen. Thus far, 113 infants have received hepatitis B immune globulin (0.5 mL at birth) and hepatitis B vaccine (three 20-micrograms doses beginning at birth or at 1 month) and have been followed up for nine to 18 months. Among these infants, 16 have become chronic carriers, an incidence of only 14.2%. All of the uninfected infants have retained high levels of antibody to surface antigen, suggesting that they have had an active immune response to the vaccine and should have long-term protection against hepatitis B virus.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Performance of a New-Generation Chemiluminescent Assay for Hepatitis B Surface Antigen
Chen and Kaplan
Clin. Chem. 2006;52:1592-1598.
ABSTRACT | FULL TEXT  

Hepatitis B Surface Antigen Prevalence Among Pregnant Women in Urban Areas: Implications for Testing, Reporting, and Preventing Perinatal Transmission
Euler et al.
Pediatrics 2003;111:1192-1197.
ABSTRACT | FULL TEXT  

Risk of Hepatitis B Transmission in Breast-fed Infants of Chronic Hepatitis B Carriers
Hill et al.
Obstet Gynecol 2002;99:1049-1052.
ABSTRACT | FULL TEXT  

Prevalence of infectious diseases in Bangladeshi women living adjacent to a truck stand: HIV/STD/hepatitis/genital tract infections
Gibney et al.
Sex. Transm. Infect. 2001;77:344-350.
ABSTRACT | FULL TEXT  

Hepatitis B Virus Biology
Seeger and Mason
Microbiol. Mol. Biol. Rev. 2000;64:51-68.
ABSTRACT | FULL TEXT  

Hepatitis B Maternal Screening, Infant Vaccination, and Infant Prophylaxis Practices in North Carolina
Pierce et al.
Arch Pediatr Adolesc Med 1999;153:619-623.
ABSTRACT | FULL TEXT  

Programme for preventing perinatal hepatitis B infection through screening of pregnant women and immunisation of infants of infected mothers in the Netherlands, 1989-92
Grosheide et al.
BMJ 1995;311:1200-1202.
ABSTRACT | FULL TEXT  

Prevention of Hepatitis B in Surgeons and Their Patients
Reese and Ockner
PERSPECT VASC SURG ENDOVASC THER 1989;2:138-147.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.